Displaying 4901 - 4950 of 14729 results
Released Company Title Industry Topic
06 Feb 2023
22:00 CET
EURONAV Euronav – Special General Meeting of 23 March 2023 50206030 Marine Transportation Other subject
06 Feb 2023
18:10 CET
GBL GBL - Transacties op GBL-aandelen 06-02-2023 30202000 Diversified Financial Services Other financial transaction
06 Feb 2023
18:09 CET
GBL GBL - Transactions sur actions propres 06-02-2023 30202000 Diversified Financial Services Other financial transaction
06 Feb 2023
18:08 CET
GBL GBL - Transactions on GBL shares 06-02-2023 30202000 Diversified Financial Services Other financial transaction
06 Feb 2023
17:40 CET
KBC ANCORA ord Update inkoopprogramma KBC Ancora tot 03 februari 2023 30101010 Banks Other subject
06 Feb 2023
17:40 CET
KBC ANCORA ord Update on share repurchase program KBC Ancora until 03 February 2023 30101010 Banks Other subject
06 Feb 2023
17:40 CET
KBC ANCORA ord Mise à jour du programme de rachat d’actions propres KBC Ancora jusqu’au 03 février 2023 30101010 Banks Other subject
06 Feb 2023
08:32 CET
TITAN CEMENT Programme de rachats d'actions 50101030 Cement Other subject
06 Feb 2023
08:31 CET
TITAN CEMENT Share buyback programme 50101030 Cement Other subject
06 Feb 2023
07:19 CET
JENSEN-GROUP Update: Inkoop eigen aandelen 50204000 Machinery: Industrial Other subject
06 Feb 2023
07:18 CET
JENSEN-GROUP Update: share buy back 50204000 Machinery: Industrial Other subject
03 Feb 2023
18:35 CET
KBC KBC Groep: KBC Bank Ireland rondt verkoop af van vrijwel al zijn activa en verplichtingen aan Bank of Ireland 30101010 Banks Other subject
03 Feb 2023
18:35 CET
KBC KBC Group: KBC Bank Ireland closes sale of substantially all of its assets and liabilities to Bank of Ireland 30101010 Banks Other subject
03 Feb 2023
18:35 CET
KBC KBC Groupe: KBC Bank Ireland clôt la vente de la quasi-totalité de ses actifs et passifs à Bank of Ireland 30101010 Banks Other subject
03 Feb 2023
14:00 CET
MDXHEALTH MDxHealth Announces Pricing of Offering of ADSs in the United States 20103010 Biotechnology Share introduction and issues
03 Feb 2023
14:00 CET
MDXHEALTH MDxHealth annonce la détermination du prix de l'offre d'ADSs aux États-Unis 20103010 Biotechnology Share introduction and issues
03 Feb 2023
09:41 CET
ATENOR Atenor acquires permit project UK Fleet House 35101010 Real Estate Holding and Development Commercial operations
03 Feb 2023
08:15 CET
BEKAERT Bekaert - Mise à jour relative au Programme de Rachat d’Actions et au Contrat de Liquidité 55102010 Iron and Steel Legal
03 Feb 2023
08:15 CET
BEKAERT Bekaert - Update over het Inkoop van Eigen Aandelen Programma en de Liquiditeitsovereenkomst 55102010 Iron and Steel Legal
03 Feb 2023
08:15 CET
BEKAERT Bekaert - Update on the Share Buyback Program and the Liquidity Agreement 55102010 Iron and Steel Legal
03 Feb 2023
07:00 CET
CELYAD ONCOLOGY Celyad Oncology publie ses résultats financiers du quatrième trimestre 2022 et ses perspectives pour 2023 20103010 Biotechnology Other subject
03 Feb 2023
07:00 CET
CELYAD ONCOLOGY Celyad Oncology Provides Fourth Quarter 2022 Business Update and 2023 Outlook 20103010 Biotechnology Other subject
02 Feb 2023
18:30 CET
EVS BROADC.EQUIPM. ANNONCE DES RESULTATS D’EVS DE L’ANNEE 2022 LE VENDREDI 17 FEVRIER 2023 15101010 Telecommunications Equipment Corporate life
02 Feb 2023
18:30 CET
EVS BROADC.EQUIPM. Evs Full Year 2022 Results to be Announced on Friday 17 February 2023 15101010 Telecommunications Equipment Corporate life
02 Feb 2023
10:30 CET
UMICORE Umicore ondertekent langetermijnovereenkomst met Terrafame voor de levering van duurzaam, koolstofarm nikkel 55201020 Specialty Chemicals Other subject
02 Feb 2023
10:30 CET
UMICORE Umicore signs long-term agreement with Terrafame for the supply of sustainable low carbon nickel 55201020 Specialty Chemicals Other subject
02 Feb 2023
10:30 CET
UMICORE Umicore signe un accord à long terme avec Terrafame pour la fourniture de nickel durable à faible teneur en carbone 55201020 Specialty Chemicals Other subject
02 Feb 2023
08:00 CET
EURONAV EURONAV PUBLICEERT RESULTATEN VIERDE KWARTAAL 2022 50206030 Marine Transportation Other subject
02 Feb 2023
08:00 CET
EURONAV EURONAV ANNOUNCES FOURTH QUARTER 2022 RESULTS 50206030 Marine Transportation Other subject
01 Feb 2023
22:00 CET
MDXHEALTH MDxHealth annonce le lancement d'une offre  d'ADSs aux États-Unis 20103010 Biotechnology Share introduction and issues
01 Feb 2023
22:00 CET
MDXHEALTH MDxHealth Announces Launch of Offering of ADSs in the United States 20103010 Biotechnology Share introduction and issues
01 Feb 2023
18:11 CET
GBL GBL - Stemrechten en noemer - Situatie op 31 januari 2023 30202000 Diversified Financial Services Corporate life
01 Feb 2023
18:10 CET
GBL GBL - Droits de vote et dénominateur - Situation au 31 janvier 2023 30202000 Diversified Financial Services Corporate life
01 Feb 2023
18:08 CET
GBL GBL - Voting rights and denominator - Situation as at January 31, 2023 30202000 Diversified Financial Services Corporate life
01 Feb 2023
17:45 CET
AZELIS GROUP NV Azelis Group NV: Transparantiekennisgeving 55201000 Chemicals: Diversified Other subject
01 Feb 2023
17:45 CET
AZELIS GROUP NV Azelis Group NV: Transparency Notification 55201000 Chemicals: Diversified Other subject
01 Feb 2023
17:40 CET
KBC ANCORA ord Bekendmaking van het totaal aantal stemrechten per 31 januari 2023 30101010 Banks Other subject
01 Feb 2023
17:40 CET
KBC ANCORA ord Announcement of the total number of voting rights as at 31 January 2023 30101010 Banks Other subject
01 Feb 2023
17:40 CET
KBC ANCORA ord Annonce du nombre total des droits de vote au 31 janvier 2023 30101010 Banks Other subject
01 Feb 2023
16:23 CET
CARE PROPERTY INVEST Publication relative à une notification de transparance 35102040 Residential REITs Commercial operations
01 Feb 2023
16:22 CET
CARE PROPERTY INVEST Openbaarmaking van een transparantiekennisgeving 35102040 Residential REITs Commercial operations
01 Feb 2023
16:22 CET
CARE PROPERTY INVEST Publication of a transparency notification 35102040 Residential REITs Commercial operations
01 Feb 2023
07:00 CET
MELEXIS Melexis Q4 et FY 2022 résultats – Chiffre d'affaires de 836.2 millions d'euros pour l’ensemble de l’année 10102010 Semiconductors Corporate life
01 Feb 2023
07:00 CET
BIOSENIC BioSenic SA : Information relative au nombre total de droits de vote et d’actions 20103010 Biotechnology Share history
01 Feb 2023
07:00 CET
MELEXIS Melexis Q4 en FY 2022 resultaten – Omzet van 836.2 miljoen EUR voor het volledige jaar 10102010 Semiconductors Corporate life
01 Feb 2023
07:00 CET
MELEXIS Melexis Q4 and FY 2022 results – Full year sales of 836.2 million EUR 10102010 Semiconductors Corporate life
01 Feb 2023
07:00 CET
BIOSENIC BioSenic SA : Information on the total number of voting rights and shares 20103010 Biotechnology Share history
31 Jan 2023
18:04 CET
LOTUS BAKERIES Press release change voting rights 45102020 Food Products Other subject
31 Jan 2023
17:48 CET
CENERGY Hellenic Cables fournira des câbles inter-réseaux pour deux projets éoliens offshore aux États-Unis 50202010 Electrical Components News contracts
31 Jan 2023
17:47 CET
CENERGY Hellenic Cables to supply inter-array cables for two offshore wind projects in the United States 50202010 Electrical Components News contracts